Protalix BioTherapeutics Competitors and Similar CompaniesClear all
iBio's competitors and similar companies include Pharming Group and UCB.
 Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date 2008 | Founding Date 1988 | Founding Date 1928 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ Bryan, US | Locations Leiden, NL HQ Leiden, NL | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 1630% decrease | Employees 404 | Employees 9,052 |
Valuation ($) | Valuation ($) 26.2 m | Valuation ($) 590.3 m | Valuation ($) 34.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) $400k (FY, 2025) | Revenue (est.) $376.1m (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $41.6m (FY, 2025) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $341m (FY, 2025) | Gross profit €7.2b (FY, 2025) |
Net income | Net income N/A | Net income $2.5m (FY, 2025) | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Pharming Group
HQ
Leiden, NL
Employees
404
Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company